Morphine Completed Phase 4 Trials for Solitary Mass / Chronic Lung Diseases Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Completed | Treatment | 4 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT01236495 | Comparison for Pethidine Requirement in Patients Received Spinal Morphine 0.2 and 0.3 mg for Post Lobectomy Analgesia |